MEDP Earnings & Financial Statements
Medpace Holdings, Inc.
$616.63
+$6.74(+1.11%)
61
Overall
50
Value
63
Tech
71
Quality
Market Cap
$17.21B
Volume
309.18K
52W Range
$373.00 - $677.90
Target Price
$616.46
MEDP earnings and financial statements: Medpace Holdings, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
MEDP Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.53B | $2.11B | $1.89B | $1.46B | $1.14B |
| Cost of revenue | $1.77B | $1.45B | $1.36B | $1.03B | $814.22M |
| Operating income | $534.93M | $446.87M | $336.82M | $278.70M | $198.62M |
| EBITDA | $580.76M | $503.29M | $382.12M | $128.47M | $219.73M |
| Net income | $451.12M | $404.39M | $282.81M | $68.63M | $181.85M |
| EPS (diluted) | $15.28 | $12.63 | $8.88 | $7.28 | $4.81 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $1.98B | $2.10B | $1.66B | $1.35B | $1.66B |
| Total liabilities | $1.52B | $1.28B | $1.10B | $966.11M | $707.01M |
| Shareholders’ equity | $459.07M | $825.54M | $558.95M | $386.39M | $952.93M |
| Cash and equivalents | $497.05M | $669.44M | $245.45M | $28.27M | $461.30M |
| Long-term debt | $113.64M | $126.23M | $142.12M | $138.87M | $130.97M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $713.22M | $608.82M | $433.37M | $388.05M | $263.33M |
| Capital expenditure | -$31.36M | -$36.55M | -$36.65M | -$36.88M | -$28.27M |
| Free cash flow | $681.87M | $572.27M | $396.73M | $351.17M | $235.06M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MEDP | $616.63 | +1.1% | 309.18K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |